untitled design

Coronavirus – AstraZeneca: Good news from antibody cocktail tests

Announcements for the test results in antibody cocktail made today, Monday (11/10) the AstraZeneca.

In particular, as announced by the company, the first injectable protection device against coronavirus, in addition to vaccines, met its main objectives in an advanced phase test, as it helped to reduce the chances of developing severe Covid-19 or death in non-hospitalized patients, as transmitted by APE-MPE.

Coronavirus – AstraZeneca: What it recently announced about a new treatment

It is recalled that in addition to vaccines and antibody cocktails, AstraZeneca performed trials for a new treatment for COVID-19 for people who do not respond well to vaccines because of a weakened immune system.

In particular, as the Anglo-Swedish company announced in early October, a test showed that this drug reduced the risk of COVID-19 symptoms in people by 77%.

Antibody therapy, called AZD7442, could protect people who do not have a strong immune response to COVID-19 vaccines, according to AstraZeneca.

You may also like

Get the latest

Stay Informed: Get the Latest Updates and Insights

 

Most popular